Zenas BioPharma Inc. (ZBIO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Zenas BioPharma Inc.

    NASDAQ: ZBIO · Real-Time Price · USD
    19.00
    2.02 (11.90%)
    At close: Sep 05, 2025, 12:56 PM

    Zenas BioPharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Revenue
    		 5M 50M n/a
    Cost of Revenue
    		 137K 113K 78K
    Gross Profit
    		 5M 50M -78K
    Operating Income
    		 -163.89M -37.15M -76.2M
    Interest Income
    		 n/a n/a n/a
    Pretax Income
    		 -156.56M -36.82M -119.28M
    Net Income
    		 -156.99M -37.12M -119.28M
    Selling & General & Admin
    		 29.75M 17.11M 13.51M
    Research & Development
    		 139.14M 60.03M 61.69M
    Other Expenses
    		 n/a 10M 1M
    Operating Expenses
    		 168.89M 87.15M 76.2M
    Interest Expense
    		 n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 168.89M 87.15M 76.2M
    Income Tax Expense
    		 429K 301K n/a
    Shares Outstanding (Basic)
    		 41.79M 38.32M 38.32M
    Shares Outstanding (Diluted)
    		 41.79M 38.32M 38.32M
    EPS (Basic)
    		 -3.76 -0.97 -3.11
    EPS (Diluted)
    		 -3.76 -0.97 -3.11
    EBITDA
    		 -163.75M -27.03M -75.12M
    EBIT
    		 -163.89M -27.15M -75.2M
    Depreciation & Amortization
    		 137K 113K 78K

    Add to Watchlist